Share Market News August 27: Infosys, Vedanta, Aurobindo Pharma, Glenmark Pharma, Ceigall, Paytm, United Drilling Tools, other stocks to track on Tuesday

Share Market News August 27: Domestic equity markets registered significant gains on Monday, with the Nifty50 rising for the eighth session in a row, driven by positive global signals following Fed Chair Jerome Powell's remarks at the Jackson Hole event, which boosted US stocks. Here's a list of stocks that are likely to be in focus on Tuesday. 

ZeeBiz WebTeam | Aug 26, 2024, 09:06 PM IST

Share Market News August 27: Domestic equity benchmarks registered sharp gains on Monday, with the Nifty50 closing higher for the eighth session in a row and reclaiming the psychologically important 25,000, boosted by positive global cues after remarks from Fed Chair Jerome Powell at the much-anticipated annual Jackson Hole event last weekend sent US stocks soaring. Most sectors enjoyed buying interest with financial, IT, energy, and auto stocks leading the rally on Dalal Street. The Sensex added 611.9 points to end at 81,698.1 while the Nifty50 settled at 25,010.61, up 187.5 points for the day.

Now, here's a list of stocks that are likely to be in focus on Tuesday, August 27:

1/10

Dividend Stocks

Dividend Stocks

Eight stocks are scheduled to trade ex-dividend on August 27: Amarjothi Spinning Mills, Jai Corp, KDDL, KSE, Manorama Industries, Panchsheel Organics, United Drilling Tools, and Windsor Machines.

2/10

Infosys CEO Salil Parekh says India offers huge opportunity, economic trajectory fantastic

Infosys CEO Salil Parekh says India offers huge opportunity, economic trajectory fantastic

"India is a huge opportunity... The growth that we are seeing for different types of work across the Indian environment is massive, and we are very much part of making sure that we engage both with private sector companies and with government agencies where we can support, for example, the government's vision on digital India," Infosys CEO Salil Parekh told news agency Press Trust of India. 

3/10

Vedanta readies Rs 30,000-crore war chest to pursue further deleveraging, growth: Report

Vedanta readies Rs 30,000-crore war chest to pursue further deleveraging, growth: Report

Vedanta Ltd has prepared a war chest of Rs 30,000 crore with recent funds raised through a qualified institutional placement (QIP), offer for sale (OFS) and dividend to pursue further deleveraging and growth, news agency Press Trust of India reported citing sources.
 

4/10

Corporate Action | Share split

Corporate Action | Share split

Aditya Vision shares are slated to trade ex-stock split on Tuesday.

5/10

Corporate Action | Buyback

Corporate Action | Buyback

Three stocks are due to trade ex-buyback on Tuesday: KDDL, Suprajit Engineering, and Technocraft Industries.

6/10

7/10

Alembic Pharma gets FDA approval for generic drug

Alembic Pharma gets FDA approval for generic drug

Alembic Pharma has received approval from the US Food & Drug Administration (USFDA) - the American health regulator - to market a generic medication used to treat moderate-to-severe psoriasis of the scalp.
 

8/10

InterGlobe Enterprises forays into Europe

InterGlobe Enterprises forays into Europe

InterGlobe Enterprises, the biggest shareholder of airline IndiGo, has opened its boutique lifestyle hotel Miiro in Paris and Barcelona and is looking to add more properties in Europe over the next couple of years.

9/10

Small finance banks in focus

Small finance banks in focus

Small finance banks' loan growth will moderate to 25-27 per cent in FY25 as against 28 per cent in FY24, according to ratings agency Crisil.

10/10

Aurobindo Pharma, Glenmark recalls products in US

Aurobindo Pharma, Glenmark recalls products in US

Drug makers Aurobindo Pharma, Glenmark and FDC are recalling products in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA), the American health regulator
 

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x